Royalty Pharma (RPRX) News
NASDAQ: RPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
56.93+0.72 (+1.28%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
RPRX news summary
We found 3 recent headlines mentioning Royalty Pharma (RPRX): 2 in the past week and 3 in the past 30 days, most often from Business Insider, GlobeNewswire, Nasdaq. For price context, RPRX is up 1.28% at $56.93. The most recent story, "Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026", was published by Business Insider on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Royalty Pharma headlines
- Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it…Business Insider
- Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2026 financial results on Wednesday, November 4, 2026 before the U.S. financial markets open. The company will…GlobeNewswire
- Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?Key PointsRevolution Medicines has just received good news around a drug meant to treat pancreatic cancer.NasdaqRPRX, RVMD